ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Peregrine Pharmaceuticals, Inc. 

14272 Franklin Avenue, Suite 100

Tustin  California  92780  U.S.A.
Phone: 714-508-6000 Fax: 714-838-5817


SEARCH JOBS




Collaborations

AVANIR Pharmaceuticals 





 Company News
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Promising Bavituximab Phase I Data Published In The Peer-Reviewed Journal Cancer Medicine In Advanced Metastatic Breast Cancer 3/31/2015 11:02:49 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Third Quarter Fiscal Year 2015 Financial Results And Recent Developments 3/13/2015 7:18:53 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 3/11/2015 7:31:52 AM
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Third Quarter Fiscal 2015 Financial Results After Market On March 12, 2015 3/6/2015 7:33:48 AM
Peregrine Pharmaceuticals, Inc. (PPHM) To Present At The 27th Annual ROTH Conference 3/3/2015 8:23:59 AM
Newly Presented Data Shows That Peregrine Pharmaceuticals, Inc. (PPHM)' PS-Targeting Antibodies Significantly Enhance Anti-Tumor Activity Of Immune Checkpoint Inhibitors PD-1 And CTLA-4 In Models Of Breast Cancer And Melanoma 2/9/2015 12:14:44 PM
Phase II Clinical Data Of Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab In Combination With Sorafenib Presented At American Society of Clinical Oncology Gastrointestinal Cancers Symposium 1/16/2015 10:33:57 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014 11:11:04 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014 8:17:00 AM
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014 3:28:26 PM
12345678910...